Search

Your search keyword '"A. Castiella"' showing total 1,813 results

Search Constraints

Start Over You searched for: Author "A. Castiella" Remove constraint Author: "A. Castiella"
1,813 results on '"A. Castiella"'

Search Results

451. The value of serum aspartate aminotransferase and gamma-glutamyl transpetidase as biomarkers in hepatotoxicity

452. Impacto de la comorbilidad en la EPOC

455. III) La necrópolis

456. II) El poblado

457. SENSORY AND INSTRUMENTAL EVALUATIONS OF TEXTURE IN CHEESES MADE FROM OVINE MILKS WITH DIFFERING FAT CONTENTS

458. Influence of Helicobacter pylori infection and eradication on blood lipids and fibrinogen

459. Medicina basada en la evidencia y rehabilitación

460. Eficacia analgésica de la electroterapia y técnicas afines: revisiones sistemáticas

461. Dysmetabolic iron overload syndrome: The need for an accurate liver iron concentration determination by magnetic resonance imaging

462. Nuevo régimen jurídico de los servicios públicos locales, tras la Ley núm. 27/2013, de 27 de diciembre, de Racionalización y Sostenibilidad de la Administración Local

463. Gender and plasma iron biomarkers, but not HFE gene mutations, increase the risk of colorectal cancer and polyps

464. Hepatotoxicity associated with statin use: analysis of the cases included in the Spanish Hepatotoxicity Registry

466. HFE gene mutations analysis in Basque hereditary haemochromatosis patients and controls

467. Campos de urnas en Navarra

468. Aplicación del biofeedback electromiográfico en la rehabilitación de la marcha en esclerosis múltiple

469. Lesión medular secundaria a cordoma

471. Tratamiento del lesionado medular en atención primaria

472. Hepatic lesion ablation with bipolar saline-enhanced radiofrequency in the audible spectrum

475. Liver iron concentration in patients referred for hyperferritinemia: multicenter analysis of the different groups according to HFE mutations and transferrin saturation index, prediction of liver iron overload in Southern Europe

476. Clinical characteristics and outcomes of elderly included in the Spanish Drug-Induced Liver Injury (DILI) Registry

481. Autoantibody presentation in drug-induced liver injury and idiopathic autoimmune hepatitis

488. Autoantibody presentation in Drug-Induced Liver Injury (DILI) and idiopathic Autoimmune Hepatitis (AIH): The influence of HLA alleles

489. Metabolic risk factors affect clinical Phenotype and outcome of Hepatotoxicity (DILI)

490. Distinguishing Drug-induced Autoimmune Hepatitis from idiopatic Autoimmune Hepatitis and Dili with Autoantibodies

492. Hepatitis tóxica hepatocelular por labetalol

493. P1098 : Influence of metabolic risk factors in hepatotoxicity (DILI) phenotype and outcome

495. Arqueología y autonomías: el caso de Navarra

497. Aprendre del Prestige

499. Leucocitosis persistente e hiperglucemia

Catalog

Books, media, physical & digital resources